Abstract
The first pneumococcal conjugate vaccine (Prevnar 7; Pfizer) contained the antigens of seven serotypes. Approved by the FDA in 2000, it has since been superseded by the 13-antigen Prevnar 13. PHiD-CV10 — a 10-valent pneumococcal conjugate vaccine in which the 10 polysaccharides are conjugated to Haemophilus influenzae protein D, tetanus toxoid, and diphtheria toxoid as the carrier proteins — was licensed in the European Union in …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
